… , the in vitro effects of edoxaban were more similar to rivaroxaban than apixaban. For
measurement of edoxaban concentration in plasma, it is possible to use the chromogenic …

… Background: Direct oral factor Xa (FXa) inhibitors interfere with … We evaluated a new device,
called DOAC Filter, and its … patients receiving direct oral FXa inhibitors (41 apixaban and 38 …

… oral anticoagulants with direct factor IIa or factor Xa inhibition has … apixaban and tackles the
generalizability of the findings with … the emerging evidence supporting the use of apixaban to …

… factor Xa inhibitors is the inhibition of prothrombinase complex-bound and clot-associated
factor Xa, … Apixaban is another highly selective and reversible inhibitor of free and clot-bound …

… Citation6 For the oral direct thrombin inhibitor, dabigatran, a … For oral direct factor Xa (FXa)
inhibitors, including apixaban, … alfa, a new investigational drug that binds to FXa inhibitors and …

… anticoagulants are warfarin and oral Factor Xa inhibitors such as rivaroxaban (Xarelto®)
and apixaban (Eliquis®). The increasing use of oral Factor Xa inhibitors has coincided with an …

… Of the factor Xa inhibitors, apixaban has the favorable profile in terms of bleeding risk, which
… lag behind new drug development, specifically regarding factor Xa inhibitors. Knowing the …

… oral anticoagulants (DOACs) targeting FXa have been developed. Rivaroxaban, apixaban,
… -1 and PAR-2, respectively, resulting in the new N-termini S 42 FLLRN 47 and S 37 LIGKV …

… Apixaban is a direct factor Xa inhibitor. It does not require antithrombin for antithrombotic
activity. Apixaban inhibits free and clot-bound factor Xa … unfamiliarity with this new method but …

… In the last decade, a new class of oral anticoagulants has … oral direct factor Xa inhibitors
as well as the indirect inhibitor … IIa and Xa inhibitors (dabigatran, rivaroxaban, apixaban and …